Home LiteratureArticle Details
PMID: 12196469 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Glucose-sensing in glucagon-like peptide-1-secreting cells.

Diabetes ·Vol. 51 ·No. 9 ·2002-09-00 ·Pages 2757-63

Reimann F, Gribble FM

Abstract

Glucagon-like peptide-1 (GLP-1) is released from intestinal L-cells in response to carbohydrate and fat in the diet. Despite the interest in GLP-1 as an antidiabetic agent, very little is known about the mechanism of stimulus-secretion coupling in L-cells. We investigated the electrophysiological events underlying glucose-induced GLP-1 release in the GLP-1-secreting cell line, GLUTag. Cells were studied using perforated-patch and standard whole-cell patch clamp recordings. GLUTag cells were largely quiescent and hyperpolarized in the absence of glucose. Increasing the glucose concentration between 0 and 20 mmol/l decreased the membrane conductance, caused membrane depolarization, and triggered the generation of action potentials. Action potentials were also triggered by tolbutamide (500 micro mol/l) and were suppressed by diazoxide (340 micro mol/l) or the metabolic inhibitor azide (3 mmol/l), suggesting an involvement of K(ATP) channels. Large tolbutamide-sensitive washout currents developed in standard whole-cell recordings, confirming the presence of K(ATP) channels. RT-PCR detected the K(ATP) channel subunits Kir6.2 and SUR1 and glucokinase. GLP-1 secretion was also stimulated by glucose over the concentration range 0-25 mmol/l and by tolbutamide. Our results suggest that glucose triggers GLP-1 release through closure of K(ATP) channels and action potential generation.

MeSH Terms
Action Potentials/drug effects Adenosine Triphosphate/physiology Animals Cell Line Cell Membrane/physiology Diazoxide/pharmacology Electric Conductivity Glucagon/metabolism Glucagon-Like Peptide 1 Glucokinase/metabolism Glucose/metabolism,pharmacology Glycosyltransferases Hypoglycemic Agents/pharmacology Membrane Proteins Peptide Fragments/metabolism Potassium Channels/drug effects,physiology Potassium Channels, Inwardly Rectifying/metabolism Protein Precursors/metabolism Repressor Proteins/metabolism Reverse Transcriptase Polymerase Chain Reaction Saccharomyces cerevisiae Proteins Tolbutamide/pharmacology
Chemicals
Hypoglycemic Agents Membrane Proteins Peptide Fragments Potassium Channels Potassium Channels, Inwardly Rectifying Protein Precursors Repressor Proteins Saccharomyces cerevisiae Proteins Glucagon-Like Peptide 1 Adenosine Triphosphate Glucagon Tolbutamide Glycosyltransferases SUR1 protein, S cerevisiae Glucokinase Glucose Diazoxide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Reimann Frank
Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
Gribble Fiona M
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
Published
2002-09-00
Pages
2757-63
Language
English
Region
United States
NLM ID
0372763
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com